Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Dec 9;9(1):18991. doi: 10.1038/s41598-019-54421-6.

2.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
3.

Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen.

Hébert V, Petit M, Maho-Vaillant M, Golinski ML, Riou G, Derambure C, Boyer O, Joly P, Calbo S.

Front Immunol. 2019 Aug 7;10:1794. doi: 10.3389/fimmu.2019.01794. eCollection 2019.

4.

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Mar 5;9(1):3525. doi: 10.1038/s41598-019-40203-7. Erratum in: Sci Rep. 2019 Dec 9;9(1):18991.

5.

Long-Term Increase of Kcnn4 Potassium Channel Surface Expression on B Cells in Pemphigus Patients after Rituximab Treatment.

Caillot F, Derambure C, Berkani N, Riou G, Maho-Vaillant M, Calbo S, Joly P, Musette P.

J Invest Dermatol. 2018 Dec;138(12):2666-2668. doi: 10.1016/j.jid.2018.05.034. Epub 2018 Jul 2. No abstract available.

6.

Anti-epileptic drugs induce cutaneous lymphocyte-associated antigen downregulation leading to potential human herpes virus-7 reactivation in clinically asymptomatic patients.

Caillot F, Andrieu E, Houivet E, Duvert-Lehembre S, Calbo S, Sabbah B, Maltete D, Martinaud O, Le Goff F, Malekpour P, Berard M, Rogez S, Joly P, Picard D, Musette P.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e41-e43. doi: 10.1111/jdv.14493. Epub 2017 Oct 10. No abstract available.

PMID:
28758263
7.

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases.

Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22.

PMID:
28342637
8.

Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate.

Lin W, Cerny D, Chua E, Duan K, Yi JT, Shadan NB, Lum J, Maho-Vaillant M, Zolezzi F, Wong SC, Larbi A, Fink K, Musette P, Poidinger M, Calbo S.

J Immunol. 2014 Sep 1;193(5):2258-66. doi: 10.4049/jimmunol.1303214. Epub 2014 Jul 30.

9.

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, Lemercier B, Le Mauff B, Maho-Vaillant M, Jacquot S, Bedane C, Bernard P, Caux F, Prost C, Delaporte E, Doutre MS, Dreno B, Franck N, Ingen-Housz-Oro S, Chosidow O, Pauwels C, Picard C, Roujeau JC, Sigal M, Tancrede-Bohin E, Templier I, Eming R, Hertl M, D'Incan M, Joly P, Musette P.

Sci Transl Med. 2013 Mar 6;5(175):175ra30. doi: 10.1126/scitranslmed.3005166.

10.

Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis.

Camous X, Calbo S, Picard D, Musette P.

Curr Opin Immunol. 2012 Dec;24(6):730-5. doi: 10.1016/j.coi.2012.07.010. Epub 2012 Oct 11. Review.

PMID:
23062470
11.

Severe drug eruptions revisited.

Calbo S.

Immunol Res. 2012 Sep;53(1-3):162-7. doi: 10.1007/s12026-012-8271-0. Review.

PMID:
22407574
12.

IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.

Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, Musette P.

Eur J Immunol. 2010 Oct;40(10):2686-91. doi: 10.1002/eji.201040673.

13.

Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.

Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P.

J Immunol. 2009 Nov 15;183(10):6207-16. doi: 10.4049/jimmunol.0803219. Epub 2009 Oct 19.

14.

Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells.

Blache C, Adriouch S, Calbo S, Drouot L, Dulauroy S, Arnoult C, Le Corre S, Six A, Seman M, Boyer O.

J Immunol. 2009 Oct 1;183(7):4182-6. doi: 10.4049/jimmunol.0901678.

15.

Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release.

Legros H, Launay S, Roussel BD, Marcou-Labarre A, Calbo S, Catteau J, Leroux P, Boyer O, Ali C, Marret S, Vivien D, Laudenbach V.

J Cereb Blood Flow Metab. 2009 Jun;29(6):1146-58. doi: 10.1038/jcbfm.2009.39. Epub 2009 Apr 15.

PMID:
19367295
16.

Functional tolerance of CD8+ T cells induced by muscle-specific antigen expression.

Calbo S, Delagrèverie H, Arnoult C, Authier FJ, Tron F, Boyer O.

J Immunol. 2008 Jul 1;181(1):408-17.

17.

Active Ca2+/calmodulin-dependent protein kinase II gamma B impairs positive selection of T cells by modulating TCR signaling.

McGargill MA, Sharp LL, Bui JD, Hedrick SM, Calbo S.

J Immunol. 2005 Jul 15;175(2):656-64.

18.

Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph.

Arstila T, Arstila TP, Calbo S, Selz F, Malassis-Seris M, Vassalli P, Kourilsky P, Guy-Grand D.

J Exp Med. 2000 Mar 6;191(5):823-34.

19.

A role for CaMKII in T cell memory.

Bui JD, Calbo S, Hayden-Martinez K, Kane LP, Gardner P, Hedrick SM.

Cell. 2000 Feb 18;100(4):457-67.

20.

Antitumor vaccination using a major histocompatibility complex (MHC) class I-restricted pseudopeptide with reduced peptide bond.

Calbo S, Guichard G, Muller S, Kourilsky P, Briand JP, Abastado JP.

J Immunother. 2000 Jan;23(1):125-30.

PMID:
10687145
21.

Tolerance to maternal immunoglobulins: resilience of the specific T cell repertoire in spite of long-lasting perturbations.

Faure M, Calbo S, Kanellopoulos J, Drapier AM, Cazenave PA, Rueff-Juy D.

J Immunol. 1999 Dec 15;163(12):6511-9.

22.

Role of peptide backbone in T cell recognition.

Calbo S, Guichard G, Bousso P, Muller S, Kourilsky P, Briand JP, Abastado JP.

J Immunol. 1999 Apr 15;162(8):4657-62.

23.

Immunological issues in vaccine trials: T-cell responses.

Kourilsky P, Bousso P, Calbo S, Gapin L.

Dev Biol Stand. 1998;95:117-24. Review.

PMID:
9855421
24.

Role of co-stimulation in CD8+ T cell activation.

Pardigon N, Bercovici N, Calbo S, Santos-Lima EC, Liblau R, Kourilsky P, Abastado JP.

Int Immunol. 1998 May;10(5):619-30.

PMID:
9645610
25.

Efficient binding of reduced peptide bond pseudopeptides to major histocompatibility complex class I molecule.

Guichard G, Calbo S, Muller S, Kourilsky P, Briand JP, Abastado JP.

J Biol Chem. 1995 Nov 3;270(44):26057-9.

Supplemental Content

Support Center